We are live on
!
Find out more
PAMU
Pictet Asset Management (UK) Portfolio holdings
AUM
$91.8B
1-Year Est. Return
47.77%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
–
AUM
$40.5B
AUM Growth
+$1.67B
(+4.3%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
11.99%
Holding
924
New
37
Increased
379
Reduced
384
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$154M |
| 2 |
PayPal
PYPL
|
+$129M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$119M |
| 4 |
Union Pacific
UNP
|
+$105M |
| 5 |
Meta Platforms (Facebook)
META
|
+$82.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$105M |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$92.4M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$88.9M |
| 4 |
Intel
INTC
|
+$71.2M |
| 5 |
Amazon
AMZN
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 18.64% |
| 3 | Industrials | 12.41% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Utilities | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vistra
VST
$48.6B
| $59.7M | 0.15% |
2,865,990
+2,798,490
| +4,146% | +$54.1M |
|
202
Advanced Drainage Systems
WMS
$10.8B
| $59.5M | 0.15% |
2,297,578
-111,322
| -5% | -$2.82M |
|
203
Analog Devices
ADI
$188B
| $59.4M | 0.15% |
651,572
+308,570
| +90% | +$28.1M |
|
204
International Paper
IP
$22.1B
| $59.2M | 0.15% |
1,169,575
+23,826
| +2% | +$1.32M |
|
|
FBR
205
DELISTED
Fibria Celulose Sa
FBR
| $59M | 0.15% |
3,024,071
+459,832
| +18% | +$8.19M |
|
206
Cigna
CI
$72.4B
| $57M | 0.14% |
339,966
-69,767
| -17% | -$13.6M |
|
207
Humana
HUM
$44.8B
| $56.8M | 0.14% |
211,244
+23,860
| +13% | +$6.46M |
|
208
Vanguard Morningstar Small-Cap ETF
VB
$82.8B
| $56.5M | 0.14% |
384,900
+29,200
| +8% | +$4.36M |
|
209
Adobe
ADBE
$105B
| $56.4M | 0.14% |
260,871
-5,000
| -2% | -$1.02M |
|
|
IRBT
210
DELISTED
iRobot
IRBT
| $55.9M | 0.14% |
871,462
-127,675
| -13% | -$9.61M |
|
|
SHPG
211
DELISTED
Shire pic
SHPG
| $55.8M | 0.14% |
373,393
-9,680
| -3% | -$1.33M |
|
212
TSMC
TSM
$2.19T
| $55.1M | 0.14% |
1,259,298
+21,580
| +2% | +$941K |
|
213
Ultragenyx Pharmaceutical
RARE
$2.66B
| $55M | 0.14% |
1,079,369
+64,900
| +6% | +$3.27M |
|
214
Toll Brothers
TOL
$14.3B
| $54.9M | 0.14% |
1,269,942
+434,538
| +52% | +$20.4M |
|
|
PPLI
215
People Inc
PPLI
$2.97B
| $54.9M | 0.14% |
1,964,911
+398,812
| +25% | +$10.5M |
|
216
ConocoPhillips
COP
$151B
| $52.7M | 0.13% |
889,381
-27,876
| -3% | -$1.58M |
|
217
Packaging Corp of America
PKG
$22.9B
| $52.6M | 0.13% |
466,938
+16,092
| +4% | +$1.94M |
|
218
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $52.6M | 0.13% |
447,947
-21,100
| -4% | -$2.49M |
|
219
Lockheed Martin
LMT
$138B
| $52.1M | 0.13% |
154,184
-6,716
| -4% | -$2.29M |
|
220
Nektar Therapeutics
NKTR
$2.55B
| $52M | 0.13% |
+32,593
| New | +$42M |
|
|
PRAH
221
DELISTED
PRA Health Sciences, Inc.
PRAH
| $51.6M | 0.13% |
621,747
+47,233
| +8% | +$4.2M |
|
222
CVS Health
CVS
$120B
| $51.3M | 0.13% |
825,111
-79,213
| -9% | -$5.68M |
|
223
Parker-Hannifin
PH
$134B
| $51.1M | 0.13% |
298,931
+220,697
| +282% | +$41.8M |
|
224
Blackrock
BLK
$178B
| $50.7M | 0.13% |
93,667
+1,184
| +1% | +$650K |
|
|
BPMC
225
DELISTED
Blueprint Medicines
BPMC
| $50.7M | 0.13% |
552,554
-53,390
| -9% | -$4.6M |
|
Similar funds
QI
FRBONY
ICOM
BAIA
BPB
BAPIM
PWA
UR
Pictet Asset Management (UK)'s Q1 2018 Portfolio in Review
As of Q1 2018, Pictet Asset Management (UK) held 924 positions worth $40.5B, up 4.3% from $38.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pictet Asset Management (UK) deployed $1.77B of net new capital in Q1 2018, opening 37 new positions and adding to 379 existing holdings. Its largest new stake was Nektar Therapeutics: 32,593 shares worth $52M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Southern Company, an estimated $105M trimmed.
- Pictet Asset Management (UK)'s largest Q1 2018 buy was Nektar Therapeutics: 32,593 shares worth $52M.
- Pictet Asset Management (UK) added most to Lam Research in Q1 2018, an estimated $154M increase.
- Pictet Asset Management (UK)'s biggest Q1 2018 reduction was Southern Company, cutting an estimated $105M.
- Pictet Asset Management (UK) fully exited Deltic Timber in Q1 2018, selling an estimated $38.8M.
- Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $40.5B portfolio in Q1 2018.
- Pictet Asset Management (UK) opened 37 new positions and closed 31 in Q1 2018.
- Pictet Asset Management (UK)'s portfolio value rose 4.3% quarter-over-quarter to $40.5B.
Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.